Home page Home page

Onsenal
celecoxib

PACKAGE LEAFLET: INFORMATION FOR THE USER


Onsenal 200 mg hard capsules celecoxib


Read all of this leaflet carefully before you start taking this medicine.


Onsenal can be taken with low dose acetylsalicylic acid (aspirin). Ask your doctor for advice before taking both of these medicines together.


Taking ONSENAL with food and drink

You can take Onsenal with or without food.

Pregnancy and breast-feeding

You must not take Onsenal if you are pregnant or if it is possible that you become pregnant. You must not take Onsenal if you are breast feeding.


Driving and using machines

If you feel dizzy or tired after taking Onsenal, do not drive or use machinery until you are feeling normal again.


Important information about some of the ingredients of Onsenal:

Onsenal contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


  1. HOW TO TAKE ONSENAL


    Always take Onsenal exactly as your doctor has told you. You should check with your doctor or pharmacist if you are unsure. The usual dose is 400 mg twice a day. You will usually take two 200 mg capsules twice a day.


    The maximum recommended daily dose is 800 mg.


    If you take more ONSENAL than you should

    If you accidentally take too many capsules, tell your doctor or pharmacist as soon as possible.


    If you forget to take ONSENAL

    Medicinal product no longer authorised

    Do not take a double dose to make up for forgotten individual doses.


  2. POSSIBLE SIDE EFFECTS


    Like all medicines, ONSENAL can cause side effects, although not everybody gets them.


    If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.


    The side effects listed below were observed in arthritis patients who took medicines with the same active ingredient as Onsenal:


    Stop taking the capsules and tell your doctor immediately

    • If you have an allergic reaction such as skin rash, swelling of the face, wheezing or difficulty breathing

    • If you have heart problems such as pain in the chest

    • If you have liver failure (symptoms may include nausea (feeling sick), diarrhoea, jaundice (your skin or the whites of your eyes look yellow))

    • If you have blistering or peeling of the skin

    • If you have severe stomach pain or any sign of bleeding in the stomach or intestines, such as passing black or bloodstained bowel movements, or vomiting blood


      Common side effects which may affect more than 1 person in 100, are listed below

      • Fluid build up with swollen ankles, legs and/or hands

      • Urinary infections

      • Sinusitis (sinus inflammation, sinus infection, blocked or painful sinuses), blocked or runny

        nose, sore throat, coughs, colds, flu-like symptoms

      • Dizziness, difficulty sleeping

      • stomach ache, diarrhoea, indigestion, wind

      • Rash, itching

      • Muscle stiffness

      • Worsening of existing allergies


      Uncommon side effects which may affect more than 1 person in a 1000, are listed below:

    • Heart failure, palpitations (awareness of heart beat), fast heart rate

    • Worsening of existing high blood pressure

    • Abnormalities in liver-related blood tests

    • Abnormalities in kidney-related blood tests

    • Anaemia (changes in red blood cells that can cause fatigue and breathlessness)

    • Anxiety, depression, tiredness, drowsiness, tingling sensations (pins and needles)

    • High levels of potassium in blood test results (can cause nausea (feeling sick), fatigue, muscle weakness or palpitations)

    • Impaired or blurred vision, ringing in the ears, mouth pain and soresConstipation, burping, stomach inflammation (indigestion, stomach ache or vomiting), worsening of inflammation of the stomach or intestine.

    • Leg cramps

    • Raised itchy rash (hives)


      Rare side effects which may affect more than 1 person in a 10,000, are listed below

    • Ulcers (bleeding) in the stomach, gullet or intestines; or rupture of the intestine (can cause stomach ache, fever, nausea, vomiting, intestinal blockage), dark or black stools, inflammation of the gullet (can cause difficulty in swallowing), inflammation of the pancreas (can lead to stomach pain)

    • Reduced number of white blood cells (which help protect the body from infection) and blood platelets (increased chance of bleeding or bruising)

    • Difficulty coordinating muscular movements

      Medicinal product no longer authorised

    • Feeling confused, changes in the way things taste

    • Increased sensitivity to light

    • Loss of hair


      Additional reactions have been reported from actual use of the active ingredient of Onsenal (in post-marketing experience). The frequencies of these reactions are difficult to determine but are generally considered to be very rare (affecting less than 1 person in every 10,000)

    • Bleeding within the brain causing death

    • Serious allergic reactions (including potentially fatal anaphylactic shock) which can cause skin rash, swelling of the face, lips, mouth, tongue or throat, wheezing or difficulty breathing; difficulty swallowing

    • Bleeding of the stomach or intestines (can lead to bloody stools or vomiting), inflammation of the intestine or colon, nausea (feeling sick)

    • Serious skin conditions such as Stevens-Johnson syndrome, exfoliative dermatitis and toxic epidermal necrolysis (can cause rash, blistering or peeling of the skin)

    • Liver failure, liver damage and severe liver inflammation (sometimes fatal or requiring liver transplant). Symptoms may include nausea (feeling sick), diarrhoea, jaundice, yellow discolouration of the skin or eyes, dark urine, pale stools, bleeding easily, itching or chills

    • Kidney problems (possible kidney failure, inflammation of the kidneys)

    • Blood clot in the blood vessels in the lungs. Symptoms may include sudden breathlessness, sharp pains when you breathe or collapse

    • Irregular heartbeat

    • Meningitis (inflammation of the membrane around the brain and spinal cord)

    • Hallucinations

    • Worsening of epilepsy (possible more frequent and/or severe seizures)

    • Inflamed blood vessels (can cause fever, aches, purple blotches on the skin)

    • Blockage of an artery or vein in the eye leading to partial or complete loss of vision, conjunctivitis, eye infection (pink eye), bleeding in the eye

    • A reduction in the number of red and white blood cells and platelets (may cause tiredness, easy bruising, frequent nose bleeds and increased risk of infections)

    • Chest pain

    • Impaired sense of smell

    • Skin discolouration (bruising), muscle pain and weakness, painful joints

    • Menstrual disturbances

    • Headache, flushing

    • Low levels of sodium in blood test results (can cause loss of appetite, headache, nausea (feeling sick), muscle cramps and weakness)


      In clinical studies where Onsenal was taken for up to 3 years to prevent spontaneous colon polyps, the following additional side effects have been observed (side effects marked with an asterisk were more common in these studies than in arthritis studies):


      Very Common side-effects (affecting more than 1 person in every 10):

    • High blood pressure*, diarrhoea*


      Common

    • Heart problems: heart attack*, angina (chest pain)

    • Stomach problems: nausea, heartburn, diverticulum (a problem with the stomach or intestine that can become painful or infected), vomiting*, irritable bowel syndrome (can include stomach ache, diarrhoea, indigestion, wind)

    • Kidney stones (which may lead to stomach or back pain, blood in urine), difficulty passing urine, increased creatinine (blood test result related to kidney function)

    • Difficulty breathing

    • Muscle spasms

    • Oedema (water retention that can cause swelling)

    • Enlarged or inflamed prostate, prostate specific antigen increased (lab test)

    • Infections of various types

      Medicinal product no longer authorised

    • Weight gain


      Uncommon

    • Stroke

    • Unstable angina (chest pain), troubles with heart valves, rhythm, or coronary arteries, or enlarged heart

    • Deep vein thrombosis (blood clot usually in the leg, which may cause pain, swelling or redness

      of the calf or breathing problems), bruising

    • Stomach infection(which can cause irritation and ulcers of the stomach and intestines), bleeding from piles/haemorrhoids, frequent bowel movements, inflamed or bleeding gums/mouth sores

    • Lower limb fracture, tendon rupture or inflammation

    • Shingles, skin infection, allergic dermatitis (dry itchy rash)

    • Floaters or haemorrhage in the eye causing blurred or impaired vision, vertigo due to inner ear troubles, difficulty speaking

    • Difficulty sleeping, excessive urination at night

    • Fatty lumps in skin or elsewhere, ganglion cyst (harmless swellings on or around joints and tendons in the hand or foot)

    • Abnormal or heavy bleeding from the vagina, painful menstruation, breast pain, ovarian cyst, menopausal symptoms

    • High levels of sodium or haemoglobin and low levels of hematocrit or testosterone in blood test

      results

    • Decreased hearing

    • Changes in blood counts


  3. HOW TO STORE ONSENAL


    Keep out of the reach and sight of children. Do not store your capsules above 30°C.

    Do not take the capsule after the ‘expiry date’ shown on the blister and carton. If your capsules are out of date, take them to your pharmacist who will get rid of them safely.


  4. FURTHER INFORMATION


What ONSENAL contains



What ONSENAL looks like and contents of the pack


The capsules are white with ‘7767‘ and ‘200‘ marked in gold ink. Onsenal is packed in blisters and supplied in boxes of 10 or 60 capsules.


Marketing Authrisation Holder


Pfizer Limited Ramsgate Road Sandwich

Kent CT13 9NJ

Medicinal product no longer authorised

United Kingdom


Manufacturer


Pfizer Manufacturing Deutschland GmbH Heinrich-Mack-Strasse 35

89257 Illertissen Germany


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.


Belgique / België /Belgien

Pfizer S.A. / N.V.

Tél/Tel: +32 (0)2 554 62 11

Luxembourg/Luxemburg

Pfizer S.A.

Tél/Tel: +32 (0)2 554 62 11


България

Pfizer HCP Corporation

Тел.: +359 2 970 4333

Magyarország

Pfizer Kft.

Tel.: +36-1-488-37-00


Česká republika

Pfizer s.r.o.

Tel.: +420-283-004-111

Malta

V.J. Salomone Pharma Ltd. Tel. +356 212201 74


Danmark

Pfizer ApS

Tlf: +45 44 20 11 00

Nederland

Pfizer BV

Tel: +31 (0)10 406 4301

Deutschland

Pfizer Pharma GmbH

Tel: +49 30 550055-51000.

Norge

Pfizer AS

Tlf: +47 67 52 61 00


Eesti

Pfizer Luxembourg SARL Eesti filiaal Tel.: +372 6 405 328

Österreich

Pfizer Corporation Austria Ges.m.b.H. Tel: +43 (0)1 521 15-0


Ελλάδα

Pfizer Hellas A.E.

Τηλ: +30 210 6785 800.

Polska

Pfizer Polska Sp. z o.o Tel.:+48 22 335 61 00


España

Pfizer S.A.

Tel: +34 91 490 99 00

Portugal

Laboratórios Pfizer, Lda. Tel: +351 21 423 5500


France

Pfizer

Tél: +33 (0)1 58 07 34 40

România

Pfizer România S.R.L. Tel: +40 21 207 28 00


Ireland

Pfizer Healthcare Ireland


Tel: +1800 633 363 (toll free)

+44 (0)1304 616161

Slovenija

Pfizer Luxembourg SARL

Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana

Tel.: + 386 1 52 11 400


Medicinal product no longer authorised

Ísland

Vistor hf

Sími: +354 535 7000

Slovenská republika

Pfizer Luxembourg SARL, organizačná zložka Tel.:+ 421-2-3355 5500


Italia

Pfizer Italia S.r.l. Tel: +39 06 33 18 21

Suomi/Finland

Pfizer Oy

Puh./Tel: +358 (0)9 43 00 40


Kύπρος

Geo. Pavlides & Araouzos Ltd. Tηλ.:+ 357 22 818087

Sverige

Pfizer AB

Tel: +46 (0)8 550-52000


Latvija

Pfizer Luxembourg SARL filiāle Latvijā Tel.: + 371 670 35 775

United Kingdom

Pfizer Limited,

Tel: +44 (0)1304 616161


Lietuva

Pfizer Luxembourg SARL filialas Lietuvoje Tel.

+ 370 52 51 4000


This leaflet was last approved in.


This medicine has been authorised under “exceptional circumstances”.

This means that because of the rarity of this disease it has been impossible to get complete information on this medicine.

The European Medicines Agency (EMA) will review any new information on the medicine every year and this leaflet will be updated as necessary.

Medicinal product no longer authorised

/. There are also links to other websites about rare diseases and treatments.